Cancer stage at diagnosis and site by location
| Variable | No. (%) of patients | p value | |
|---|---|---|---|
| On reserve | Off reserve | ||
| Cancer stage | |||
| I | 202 (21.7) | 160 (26.9) | 0.02 |
| II | 207 (22.3) | 133 (22.4) | 0.95 |
| III | 176 (18.9) | 109 (18.4) | 0.8 |
| IV | 216 (23.2) | 126 (21.2) | 0.4 |
| Unknown | 129 (13.9) | 66 (11.1) | 0.1 |
| Cancer site | |||
| Bladder | ≤ 5 | 8 (1.3) | 0.09 |
| Breast | 99 (10.6) | 111 (18.7) | < 0.001 |
| Cervix | 19 (2.0) | 26 (4.4) | 0.009 |
| Chronic lymphocytic leukemia | ≤ 5 | ≤ 5 | 0.08 |
| Colorectal | 153 (16.4) | 87 (14.6) | 0.3 |
| Kidney | 96 (10.3) | 40 (6.7) | 0.02 |
| Lung and bronchus | 131 (14.1) | 74 (12.5) | 0.4 |
| Melanoma of the skin | ≤ 5 | ≤ 5 | ≤ 5 |
| Non-Hodgkin lymphoma | 33 (3.5) | 32 (5.4) | 0.08 |
| Ovary | 25 (2.7) | 7 (1.2) | 0.04 |
| Pancreas | 19 (2.0) | 13 (2.2) | 0.8 |
| Prostate | 100 (10.8) | 34 (5.7) | < 0.001 |
| Stomach | 18 (1.9) | 11 (1.8) | 0.9 |
| Thyroid | 10 (1.1) | 10 (1.7) | 0.3 |
| Uterus | 19 (2.0) | 19 (3.2) | 0.2 |
| Other | 197 (21.2) | 113 (19.0) | 0.3 |